Practically speaking about lupus anticoagulants and women's health: Part 1 of a series to learn about a paradoxical problem

Practically speaking about lupus anticoagulants and women's health:
Part 1 of a series to learn about a paradoxical problem

Lupus anticoagulants are consistently present in patients at risk of thrombosis as a result of underlying antiphospholipid syndrome (aPS), a dangerous disorder treated by prophylactic anticoagulation using well-established methods. Our webinar, part of an ongoing series will give an overview of antiphospholipid syndrome, available clotting-based methods, validation procedures, and link in relevance to women’s health. The information provided will bring together different pieces of the overall but paradoxical picture of aPS, allowing for a full picture of the relevance in the overall care pathway.

Learning Objectives

1. Provide overview of lupus anticoagulants assays with emphasis not only on overall methods but commonly performed validation procedures
2. Present linkage of lupus anticoagulants to patient care pathway for confirmed aPS patients
3. Demonstrate relevance of aPS to real life patient situations